Skip to main content

Blog

EU Regulatory Insights

Regulatory updates, compliance guides, and EU market entry insights for supplement brands, cosmetic companies, and North American exporters.

EU Cosmetics Regulation 1223/2009

When Your Cosmetic Becomes a Medicinal Product: The Borderline Classification Risk Under EU Regulation 1223/2009

High-concentration actives can trigger ANSM reclassification of your cosmetic as a medicinal product. What's at stake — and how to assess the risk before EU market entry.

Nour Abochama
Read →
USA FDA Compliance for European Exporters

When Your EU Cosmetic Becomes an FDA Drug: What European Exporters Must Know

If your EU-approved cosmetic makes the wrong claim, FDA reclassifies it as a drug. Here's what European exporters must know before entering the US market.

Nour Abochama
Read →
EU Cosmetics Regulation 1223/2009

Water Activity Testing in Cosmetics: The Microbial Safety Gap Hiding in Your EU Product Information File

EU Cosmetics Regulation 1223/2009 demands robust microbiological safety justification. Water activity (Aw) testing is the metric most brands overlook — and regulators are noticing.

Nour Abochama
Read →
EU Cosmetics Regulation 1223/2009

The EU Cosmetic Product Safety Report: What Regulation (EC) No 1223/2009 Requires in Part A and Part B

A technical breakdown of the CPSR under Regulation EC No 1223/2009 — what Part A must document and what Part B must conclude for EU market compliance.

Nour Abochama
Read →
USA FDA Compliance for European Exporters

EU Sunscreen Ingredients That FDA Has Not Approved: The UV Filter Gap European Brands Must Navigate

EU Regulation 1223/2009 approves ~27 UV filters; FDA considers only 2 GRASE. Here's what that compliance gap means for European brands targeting the US market.

Nour Abochama
Read →
Herbal & Supplement Testing (rare in Europe)

Why European Regulators Are Scrutinising Ashwagandha — and What Supplement Brands Must Test Before Going to Market

ANSES flagged 27 adverse event reports linked to ashwagandha; Denmark restricted high-dose products. What EU supplement brands must test before launch.

Nour Abochama
Read →
EU Cosmetics Regulation 1223/2009

EU Fragrance Allergen Labeling: The August 2026 Deadline That Changes What Goes on Your Cosmetics Label

With 11 days to August 2026, expanded fragrance allergen labeling under EU Cosmetics Regulation 1223/2009 applies to all new products. Here's your compliance checklist.

Nour Abochama
Read →
EU Cosmetics Regulation 1223/2009

REACH Compliance for Cosmetics Manufacturers: What SVHCs Mean for Your Formulations

REACH and EU Regulation 1223/2009 impose overlapping but distinct duties on cosmetics brands. Here's what SVHCs, the Candidate List, and the SCIP database actually require.

Nour Abochama
Read →
EU Cosmetics Regulation 1223/2009

In Vitro Safety Testing for EU Cosmetics: Which Methods SCCS Accepts Under Regulation 1223/2009

EU Regulation EC 1223/2009 bans animal testing. Here's which in vitro methods SCCS accepts for your safety report — and where brands still face data gaps.

Nour Abochama
Read →
GMP / ISO 22716 Compliance

ISO 22716 GMP vs FDA Cosmetics Requirements: The Gap Analysis European Exporters Need

European cosmetics manufacturers certified to ISO 22716 face critical gaps under FDA MoCRA. Here's the gap analysis you need before exporting to the US.

Nour Abochama
Read →
EU Cosmetics Regulation 1223/2009

UK vs EU Cosmetics Regulation After Brexit: A Practical Guide for Brands Entering Both Markets

UK and EU cosmetics regulation have diverged since Brexit. A practical guide to Responsible Persons, notifications, and REACH for brands entering both markets.

Nour Abochama
Read →
Botanical Identity & Adulteration

Botanical Adulteration in EU Herbal Supplements: Why DNA Barcoding Is Overturning Traditional Identity Testing

68% of herbal products in a landmark barcoding study contained undisclosed species. Here's why DNA testing is changing botanical identity verification for EU supplement brands.

Nour Abochama
Read →
EU Cosmetics Regulation 1223/2009

EU UV Filter Approvals: Why Sunscreen Brands Are Still Waiting — and What Annex VI Compliance Actually Requires in 2026

EU Annex VI permits fewer than 30 UV filters, and adding one takes years. Here's how the SCCS approval process works and what sunscreen brands must get right under EC No 1223/2009.

Nour Abochama
Read →
EU Cosmetics Regulation 1223/2009

What 'Natural', 'Anti-Ageing', and 'Clinically Proven' Must Actually Prove Under EU Cosmetics Law

Regulation 655/2013 sets six strict criteria for EU cosmetic claims. What 'natural', 'anti-ageing', and 'clinically proven' must actually prove — and where brands get caught.

Nour Abochama
Read →
EU Cosmetics Regulation 1223/2009

CMR Substances in EU Cosmetics: How CLP Reclassifications Create Overnight Formulation Bans

When a substance is reclassified as CMR under EU CLP Regulation, it can instantly become prohibited in cosmetics under Article 15 of Regulation 1223/2009. Here's what brands must monitor.

Nour Abochama
Read →
EU Cosmetics Regulation 1223/2009

Cosmetics Stability Testing Under EU Regulation 1223/2009: What Your Product Information File Actually Needs

Stability testing is a legal requirement under EU Regulation 1223/2009. Here's what your PIF must include to support a compliant cosmetics safety assessment.

Nour Abochama
Read →
USA FDA Compliance for European Exporters

EU Sunscreens Are OTC Drugs in the USA: The FDA Compliance Gap European Exporters Miss

EU sunscreens are classified as OTC drugs in the USA — not cosmetics. Learn the formulation, labeling, GMP, and registration gaps European exporters must close before shipping.

Nour Abochama
Read →
EU Cosmetics Regulation 1223/2009

Nitrosamines in EU Cosmetics: The In-Formulation Risk That Every CPSR Must Address Under EC Regulation 1223/2009

Nitrosamines can form inside your finished cosmetic even when every ingredient is individually compliant. Here's what EC Regulation 1223/2009 and the SCCS require you to assess.

Nour Abochama
Read →